



@article {3262,
	title = {Long-term effects of chronic cocaine exposure throughout adolescence on anxiety and stress responsivity in a Wistar rat model},
	journal = {Neuroscience},
	volume = {277},
	year = {2014},
	note = {Export Date: 21 November 2014},
	month = {2014},
	pages = {343 - 355},
	abstract = {Adolescents display increased vulnerability to engage in drug experimentation. This is often considered a risk factor for later drug abuse. In this scenario, the permanent effects of cocaine exposure during adolescence on anxiety levels and stress responsivity, which may result in behavioral phenotypes prone to addiction, are now starting to be unveiled. Thus, the purpose of the present study was to evaluate the long-lasting effects of chronic cocaine administration during adolescence, on anxiety-like behavior and on stress response. Adolescent male Wistar rats were daily administered 45-mg cocaine/kg of body weight in three equal intraperitoneal doses with 1-h interval, from postnatal day (PND) 35 to 50. The effects of cocaine administration on anxiety levels, assessed in the Elevated Plus Maze (EPM), and on social stress response, assessed in the resident-intruder paradigm (R/I), were evaluated 10. days after withdrawal, when rats were reaching the adulthood. The underlying dopaminergic activity, and the corticosterone and testosterone levels were determined. Our results showed that cocaine induced long-lasting alterations in the hypothalamus-pituitary-adrenals (HPA) axis function and in testosterone levels. Such alterations resulted in significant and enduring changes in behavioral responses to environmental challenges, such as the EPM and R/I, including the evaluation of potential threats that may lead to high-risk behavior and low-benefit choices. This was further supported by an altered dopaminergic function in the amygdala and hippocampus. The present findings provide new insights into how the use of cocaine during adolescent development may modulate emotional behavior later in life. Compromised ability to recognize and deal with potential threats is an important risk factor to perpetuate compulsive drug seeking and relapse susceptibility. {\textcopyright} 2014 IBRO.},
	keywords = {Adolescence, anxiety, Cocaine, corticosterone, Dopaminergic system, Social stress},
	url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-84905366454\&partnerID=40\&md5=d2e5800617d04560c58988a8957e2a5b},
	author = {Alves, C.J. and Magalh{\~a}es, A. and Melo, P. and De Sousa, L. and Tavares, M.A. and Monteiro, P.R.R. and Summavielle, T.}
}
@booklet {2829,
	title = {Bacterial-binding chitosan microspheres for gastric infection treatment and prevention},
	howpublished = {Acta Biomaterialia},
	volume = {9},
	year = {2013},
	note = {Export Date: 12 December 2013Source: Scopus},
	month = {2013///},
	pages = {9370 - 9378},
	url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-84887160912\&partnerID=40\&md5=dd414f3b1e57bee7c37bc37a44983d27},
	author = {Gon{\c c}alves, I.C. and Magalh{\~a}es, A. and Fernandes, M. and Rodrigues, I.V. and Reis, C.A. and Martins, M.C.L.}
}
@article {2835,
	title = {Bioengineered surfaces promote specific protein-glycan mediated binding of the gastric pathogen Helicobacter pylori},
	journal = {Acta Biomaterialia},
	volume = {9},
	year = {2013},
	note = {Export Date: 12 December 2013Source: Scopus},
	month = {2013///},
	pages = {8885 - 8893},
	url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-84885052038\&partnerID=40\&md5=0d17eb0f95d76eb18ea20ef7f33c8192},
	author = {Parreira, P. and Magalh{\~a}es, A. and Reis, C.A. and Bor{\'e}n, T. and Leckband, D. and Martins, M.C.L.}
}
@article {2879,
	title = {E-cadherin and adherens-junctions stability in gastric carcinoma: Functional implications of glycosyltransferases involving N-glycan branching biosynthesis, N-acetylglucosaminyltransferases III and v},
	journal = {Biochimica et Biophysica Acta - General Subjects},
	volume = {1830},
	year = {2013},
	note = {Cited By (since 1996):1Export Date: 12 December 2013Source: Scopus},
	month = {2013///},
	pages = {2690 - 2700},
	url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-84873589547\&partnerID=40\&md5=ea238ee2045a2bbfb910b24526aac863},
	author = {Pinho, S.S. and Figueiredo, J. and Cabral, J. and Carvalho, S. and Dourado, J. and Magalh{\~a}es, A. and G{\"a}rtner, F. and Mendon{\c c}a, A.M. and Isaji, T. and Gu, J. and Carneiro, F. and Seruca, R. and Taniguchi, N. and Reis, C.A.}
}
@article {2207,
	title = {Methamphetamine mimics the neurochemical profile of aging in rats and impairs recognition memory},
	journal = {NeuroToxicologyNeuroToxicology},
	volume = {33},
	year = {2012},
	note = {Export Date: 21 November 2012Source: ScopusCODEN: NRTXDdoi: 10.1016/j.neuro.2012.03.002PubMed ID: 22433442Language of Original Document: EnglishCorrespondence Address: Melo, P.; Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto, Portugal; email: pmelo@ibmc.up.ptChemicals/CAS: dopamine, 51-61-6, 62-31-7; methamphetamine, 28297-73-6, 51-57-0, 537-46-2, 7632-10-2; serotonin, 50-67-9; sodium chloride, 7647-14-5; Hydroxyindoleacetic Acid, 54-16-0; Methamphetamine, 537-46-2; Serotonin, 50-67-9References: Ali, S.F., David, S.N., Newport, G.D., Age-related susceptibility to MPTP-induced neurotoxicity in mice (1993) Neurotoxicology, 14, pp. 29-34;Alves, E., Binienda, Z., Carvalho, F., Alves, C.J., Fernandes, E., Bastos, M.D.L., Acetyl-l-carnitine provides effective in vivo neuroprotection over 3,4-methylenedioximethamphetamine-induced mitochondrial neurotoxicity in the adolescent rat brain (2009) Neuroscience, 158, pp. 514-523; 
Belcher, A.M., O{\textquoteright}Dell, S.J., Marshall, J.F., A sensitizing regimen of methamphetamine causes impairments in a novelty preference task of object recognition (2006) Behav Brain Res, 170, pp. 167-172; 
Belcher, A.M., Feinstein, E.M., O{\textquoteright}Dell, S.J., Marshall, J.F., Methamphetamine influences on recognition memory: comparison of escalating and single-day dosing regimens (2008) Neuropsychopharmacology, 33, pp. 1453-1463; 
Bergado, J.A., Almaguer, W., Rojas, Y., Capdevila, V., Frey, J.U., Spatial and emotional memory in aged rats: a behavioral-statistical analysis (2011) Neuroscience, 172, pp. 256-269; 
Biagioni, F., Pellegrini, A., Ruggieri, S., Murri, L., Paparelli, A., Fornai, F., Behavioural sensitisation during dopamine replacement therapy in Parkinson{\textquoteright}s disease is reminiscent of the addicted brain (2009) Curr Top Med Chem, 9, pp. 894-902; 
Bisagno, V., Ferguson, D., Luine, V.N., Short toxic methamphetamine schedule impairs object recognition task in male rats (2002) Brain Res, 940, pp. 95-101; 
Boger, H.A., Middaugh, L.D., Patrick, K.S., Ramamoorthy, S., Denehy, E.D., Zhu, H., Long-term consequences of methamphetamine exposure in young adults are exacerbated in glial cell line-derived neurotrophic factor heterozygous mice (2007) J Neurosci, 27, pp. 8816-8825; 
Boger, H.A., Middaugh, L.D., Granholm, A.C., McGinty, J.F., Minocycline restores striatal tyrosine hydroxylase in GDNF heterozygous mice but not in methamphetamine-treated mice (2009) Neurobiol Dis, 33, pp. 459-466; 
Boguszewski, P., Zagrodzka, J., Emotional changes related to age in rats - a behavioral analysis (2002) Behav Brain Res, 133, pp. 323-332; 
Bubenikova-Valesova, V., Kacer, P., Syslova, K., Rambousek, L., Janovsky, M., Schutova, B., Prenatal methamphetamine exposure affects the mesolimbic dopaminergic system and behavior in adult offspring (2009) Int J Dev Neurosci, 27, pp. 525-530; 
Camarasa, J., Rodrigo, T., Pubill, D., Escubedo, E., Memantine is a useful drug to prevent the spatial and non-spatial memory deficits induced by methamphetamine in rats (2010) Pharmacol Res, 62, pp. 450-456; 
Capela, J.P., Carmo, H., Remiao, F., Bastos, M.L., Meisel, A., Carvalho, F., Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview (2009) Mol Neurobiol, 39, pp. 210-271; 
Carfagna, N., Trunzo, F., Moretti, A., Brain catecholamine content and turnover in aging rats (1985) Exp Gerontol, 20, pp. 265-269; 
Carnes, B.A., Staats, D.O., Sonntag, W.E., Does senescence give rise to disease? (2008) Mech Ageing Dev, 129, pp. 693-699; 
Carvalho, F., How bad is accelerated senescence in consumers of drugs of abuse? (2009) Adicciones, 21, pp. 99-104; 
Chang, L., Alicata, D., Ernst, T., Volkow, N., Structural and metabolic brain changes in the striatum associated with methamphetamine abuse (2007) Addiction, 102 (SUPPL. 1), pp. 16-32; 
Cretzmeyer, M., Sarrazin, M.V., Huber, D.L., Block, R.I., Hall, J.A., Treatment of methamphetamine abuse: research findings and clinical directions (2003) J Subst Abuse Treat, 24, pp. 267-277; 
Cubells, J.F., Rayport, S., Rajendran, G., Sulzer, D., Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress (1994) J Neurosci, 14, pp. 2260-2271; 
Dowling, G.J., Weiss, S.R.B., Condon, T.P., Drugs of abuse and the aging brain (2008) Neuropsychopharmacology, 33, pp. 209-218; 
Eisch, A.J., Schmued, L.C., Marshall, J.F., Characterizing cortical neuron injury with Fluoro-Jade labeling after a neurotoxic regimen of methamphetamine (1998) Synapse, 30, pp. 329-333; 
Ennaceur, A., Neave, N., Aggleton, J.P., Spontaneous object recognition and object location memory in rats: the effects of lesions in the cingulate cortices, the medial prefrontal cortex, the cingulum bundle and the fornix (1997) Exp Brain Res, 113, pp. 509-519; 
Ennaceur, A., Michalikova, S., Bradford, A., Ahmed, S., Detailed analysis of the behavior of Lister and Wistar rats in anxiety, object recognition and object location tasks (2005) Behav Brain Res, 159, pp. 247-266; 
Erickson, C.A., Barnes, C.A., The neurobiology of memory changes in normal aging (2003) Exp Gerontol, 38, pp. 61-69; 
Esteban, S., Garau, C., Aparicio, S., Moranta, D., Barcelo, P., Fiol, M.A., Chronic melatonin treatment and its precursor l-tryptophan improve the monoaminergic neurotransmission and related behavior in the aged rat brain (2010) J Pineal Res, 48, pp. 170-177; 
Esteban, S., Garau, C., Aparicio, S., Moranta, D., Barcelo, P., Ramis, M., Improving effects of long-term growth hormone treatment on monoaminergic neurotransmission and related behavioral tests in aged rats (2010) Rejuvenation Res, 13, pp. 707-716; 
Fleckenstein, A.E., Metzger, R.R., Wilkins, D.G., Gibb, J.W., Hanson, G.R., Rapid and reversible effects of methamphetamine on dopamine transporters (1997) J Pharmacol Exp Ther, 282, pp. 834-838; 
Friedman, S.D., Castaneda, E., Hodge, G.K., Long-term monoamine depletion, differential recovery, and subtle behavioral impairment following methamphetamine-induced neurotoxicity (1998) Pharmacol Biochem Behav, 61, pp. 35-44; 
Frost, D.O., Cadet, J.L., Effects of methamphetamine-induced neurotoxicity on the development of neural circuitry: a hypothesis (2000) Brain Res Brain Res Rev, 34, pp. 103-118; 
Fumagalli, F., Gainetdinov, R.R., Wang, Y.M., Valenzano, K.J., Miller, G.W., Caron, M.G., Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice (1999) J Neurosci, 19, pp. 2424-2431; 
Garwood, E.R., Bekele, W., McCulloch, C.E., Christine, C.W., Amphetamine exposure is elevated in Parkinson{\textquoteright}s disease (2006) Neurotoxicology, 27, pp. 1003-1006; 
Gasbarri, A., Verney, C., Innocenzi, R., Campana, E., Pacitti, C., Mesolimbic dopaminergic neurons innervating the hippocampal formation in the rat: a combined retrograde tracing and immunohistochemical study (1994) Brain Res, 668, pp. 71-79; 
Graham, D.G., Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones (1978) Mol Pharmacol, 14, pp. 633-643; 
Guilarte, T.R., Is methamphetamine abuse a risk factor in parkinsonism? (2001) Neurotoxicology, 22, pp. 725-731; 
Harvey, D.C., Lacan, G., Tanious, S.P., Melega, W.P., Recovery from methamphetamine induced long-term nigrostriatal dopaminergic deficits without substantia nigra cell loss (2000) Brain Res, 871, pp. 259-270; 
Hotchkiss, A.J., Gibb, J.W., Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain (1980) J Pharmacol Exp Ther, 214, pp. 257-262; 
Jones, S.R., Gainetdinov, R.R., Wightman, R.M., Caron, M.G., Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter (1998) J Neurosci, 18, pp. 1979-1986; 
Kalechstein, A.D., Newton, T.F., Green, M., Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence (2003) J Neuropsychiatry Clin Neurosci, 15, pp. 215-220; 
Kish, S.J., Shannak, K., Rajput, A., Deck, J.H., Hornykiewicz, O., Aging produces a specific pattern of striatal dopamine loss: implications for the etiology of idiopathic Parkinson{\textquoteright}s disease (1992) J Neurochem, 58, pp. 642-648; 
Koda, L.Y., Gibb, J.W., Adrenal and striatal tyrosine hydroxylase activity after methamphetamine (1973) J Pharmacol Exp Ther, 185, pp. 42-48; 
Lu, P., Mamiya, T., Lu, L.L., Mouri, A., Niwa, M., Kim, H.C., Silibinin attenuates cognitive deficits and decreases of dopamine and serotonin induced by repeated methamphetamine treatment (2010) Behav Brain Res, 207, pp. 387-393; 
Luine, V., Bowling, D., Hearns, M., Spatial memory deficits in aged rats - contributions of monoaminergic systems (1990) Brain Res, 537, pp. 271-278; 
Luparini, M.R., Del Vecchio, A., Barillari, G., Magnani, M., Prosdocimi, M., Cognitive impairment in old rats: a comparison of object displacement, object recognition and water maze (2000) Aging (Milano), 12, pp. 264-273; 
Marshall, J.F., Belcher, A.M., Feinstein, E.M., O{\textquoteright}Dell, S.J., Methamphetamine-induced neural and cognitive changes in rodents (2007) Addiction, 102, pp. 61-69; 
Melega, W.P., Williams, A.E., Schmitz, D.A., DiStefano, E.W., Cho, A.K., Pharmacokinetic and pharmacodynamic analysis of the actions of d-amphetamine and d-methamphetamine on the dopamine terminal (1995) J Pharmacol Exp Ther, 274, pp. 90-96; 
Melo, P., Zanon-Moreno, V., Alves, C.J., Magalhaes, A., Tavares, M.A., Pinazo-Duran, M.D., Oxidative stress response in the adult rat retina and plasma after repeated administration of methamphetamine (2010) Neurochem Int, 56, pp. 431-436; 
Meredith, C.W., Jaffe, C., Ang-Lee, K., Saxon, A.J., Implications of chronic methamphetamine use: a literature review (2005) Harv Rev Psychiatry, 13, pp. 141-154; 
Metzger, R.R., Haughey, H.M., Wilkins, D.G., Gibb, J.W., Hanson, G.R., Fleckenstein, A.E., Methamphetamine-induced rapid decrease in dopamine transporter function: role of dopamine and hyperthermia (2000) J Pharmacol Exp Ther, 295, pp. 1077-1085; 
Miguez, J.M., Aldegunde, M., Paz-Valinas, L., Recio, J., Sanchez-Barcelo, E., Selective changes in the contents of noradrenaline, dopamine and serotonin in rat brain areas during aging (1999) J Neural Transm, 106, pp. 1089-1098; 
Moretti, A., Carfagna, N., Trunzo, F., Effect of aging on monoamines and their metabolites in the rat brain (1987) Neurochem Res, 12, pp. 1035-1039; 
Nagai, T., Takuma, K., Dohniwa, M., Ibi, D., Mizoguchi, H., Kamei, H., Repeated methamphetamine treatment impairs spatial working memory in rats: reversal by clozapine but not haloperidol (2007) Psychopharmacology, 194, pp. 21-32; 
Nash, J.F., Yamamoto, B.K., Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine (1992) Brain Res, 581, pp. 237-243; 
Nordahl, T.E., Salo, R., Leamon, M., Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition. A review (2003) J Neuropsychiatry Clin Neurosci, 15, pp. 317-325; 
Ossowska, K., Disturbances in neurotransmission processes in aging and age-related diseases (1993) Pol J Pharmacol, 45, pp. 109-131; 
Ponzio, F., Brunello, N., Algeri, S., Catecholamine synthesis in brain of ageing rat (1978) J Neurochem, 30, pp. 1617-1620; 
Ponzio, F., Calderini, G., Lomuscio, G., Vantini, G., Toffano, G., Algeri, S., Changes in monoamines and their metabolite levels in some brain regions of aged rats (1982) Neurobiol Aging, 3, pp. 23-29; 
Pradhan, S.N., Central neurotransmitters and aging (1980) Life Sci, 26, pp. 1643-1656; 
Reis, D.J., Ross, R.A., Joh, T.H., Changes in the activity and amounts of enzymes synthesizing catecholamines and acetylcholine in brain, adrenal medulla, and sympathetic ganglia of aged rat and mouse (1977) Brain Res, 136, pp. 465-474; 
Ricaurte, G.A., Schuster, C.R., Seiden, L.S., Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study (1980) Brain Res, 193, pp. 153-163; 
Ricaurte, G.A., Guillery, R.W., Seiden, L.S., Schuster, C.R., Moore, R.Y., Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain (1982) Brain Res, 235, pp. 93-103; 
Ricaurte, G.A., Fuller, R.W., Perry, K.W., Seiden, L.S., Schuster, C.R., Fluoxetine increases long-lasting neostriatal dopamine depletion after administration of d-methamphetamine and d-amphetamine (1983) Neuropharmacology, 22, pp. 1165-1169; 
Ricaurte, G.A., Seiden, L.S., Schuster, C.R., Increased dopamine metabolism in the rat neostriatum after toxic doses of d-methylamphetamine (1983) Neuropharmacology, 22, pp. 1383-1388; 
Robinson, T.E., Yew, J., Paulson, P.E., Camp, D.M., The long-term effects of neurotoxic doses of methamphetamine on the extracellular concentration of dopamine measured with microdialysis in striatum (1990) Neurosci Lett, 110, pp. 193-198; 
Rogers, J.L., De Santis, S., See, R.E., Extended methamphetamine self-administration enhances reinstatement of drug seeking and impairs novel object recognition in rats (2008) Psychopharmacology (Berl), 199, pp. 615-624; 
Sabol, K.E., Roach, J.T., Broom, S.L., Ferreira, C., Preau, M.M., Long-term effects of a high-dose methamphetamine regimen on subsequent methamphetamine-induced dopamine release in vivo (2001) Brain Res, 892, pp. 122-129; 
Salo, R., Ursu, S., Buonocore, M.H., Leamon, M.H., Carter, C., Impaired prefrontal cortical function and disrupted adaptive cognitive control in methamphetamine abusers: a functional magnetic resonance imaging study (2009) Biol Psychiatry, 65, pp. 706-709; 
Santiago, M., Machado, A., Reinoso-Suarez, F., Cano, J., Changes in biogenic amines in rat hippocampus during development and aging (1988) Life Sci, 42, pp. 2503-2508; 
Schroder, N., O{\textquoteright}Dell, S.J., Marshall, J.F., Neurotoxic methamphetamine regimen severely impairs recognition memory in rats (2003) Synapse, 49, pp. 89-96; 
Schwendt, M., Rocha, A., See, R.E., Pacchioni, A.M., McGinty, J.F., Kalivas, P.W., Extended methamphetamine self-administration in rats results in a selective reduction of dopamine transporter levels in the prefrontal cortex and dorsal striatum not accompanied by marked monoaminergic depletion (2009) J Pharmacol Exp Ther, 331, pp. 555-562; 
Scott, J.C., Woods, S.P., Matt, G.E., Meyer, R.A., Heaton, R.K., Atkinson, J.H., Neurocognitive effects of methamphetamine: a critical review and meta-analysis (2007) Neuropsychol Rev, 17, pp. 275-297; 
Seiden, L.S., Sabol, K.E., Ricaurte, G.A., Amphetamine: effects on catecholamine systems and behavior (1993) Annu Rev Pharmacol Toxicol, 33, pp. 639-677; 
Sekine, Y., Iyo, M., Ouchi, Y., Matsunaga, T., Tsukada, H., Okada, H., Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET (2001) Am J Psychiatry, 158, pp. 1206-1214; 
Simon, S.L., Domier, C., Carnell, J., Brethen, P., Rawson, R., Ling, W., Cognitive impairment in individuals currently using methamphetamine (2000) Am J Addict, 9, pp. 222-231; 
Simon, S.L., Dacey, J., Glynn, S., Rawson, R., Ling, W., The effect of relapse on cognition in abstinent methamphetamine abusers (2004) J Subst Abuse Treat, 27, pp. 59-66; 
Treit, D., Fundytus, M., Thigmotaxis as a test for anxiolytic activity in rats (1988) Pharmacol Biochem Behav, 31, pp. 959-962; 
Troen, B.R., The biology of aging (2003) Mt Sinai J Med, 70, pp. 3-22; 
Venero, J.L., Machado, A., Cano, J., Turnover of dopamine and serotonin and their metabolites in the striatum of aged rats (1991) J Neurochem, 56, pp. 1940-1948; 
Venero, J.L., de la Roza, C., Machado, A., Cano, J., Age-related changes on monoamine turnover in hippocampus of rats (1993) Brain Res, 631, pp. 89-96; 
Volkow, N.D., Chang, L., Wang, G.J., Fowler, J.S., Leonido-Yee, M., Franceschi, D., Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers (2001) Am J Psychiatry, 158, pp. 377-382; 
Volz, T.J., Fleckenstein, A.E., Hanson, G.R., Methamphetamine-induced alterations in monoamine transport: implications for neurotoxicity, neuroprotection and treatment (2007) Addiction, 102 (SUPPL. 1), pp. 44-48; 
Vorhees, C.V., Reed, T.M., Morford, L.L., Fukumura, M., Wood, S.L., Brown, C.A., Periadolescent rats (P41-50) exhibit increased susceptibility to d-methamphetamine-induced long-term spatial and sequential learning deficits compared to juvenile (P21-30 or P31-40) or adult rats (P51-60) (2005) Neurotoxicol Teratol, 27, pp. 117-134; 
Vupputuri, S., Batuman, V., Muntner, P., Bazzano, L.A., Lefante, J.J., Whelton, P.K., Risk for mild kidney function decline associated with illicit drug use among hypertensive men (2004) Am J Kidney Dis, 43, pp. 629-635; 
Wagner, G.C., Ricaurte, G.A., Johanson, C.E., Schuster, C.R., Seiden, L.S., Amphetamine induces depletion of dopamine and loss of dopamine uptake sites in caudate (1980) Neurology, 30, pp. 547-550; 
Wagner, G.C., Ricaurte, G.A., Seiden, L.S., Schuster, C.R., Miller, R.J., Westley, J., Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine (1980) Brain Res, 181, pp. 151-160; 
White, I.M., Minamoto, T., Odell, J.R., Mayhorn, J., White, W., Brief exposure to methamphetamine (METH) and phencyclidine (PCP) during late development leads to long-term learning deficits in rats (2009) Brain Res, 1266, pp. 72-86
},
	month = {2012///},
	pages = {491 - 499},
	abstract = {Brain neurochemistry and cognition performance are thought to decline with age. Accumulating data indicate that similar events occur after prolonged methamphetamine (MA) exposure. Using the rat as a model, the present study was designed to uncover common alteration patterns in brain neurochemistry and memory performance between aging and prolonged MA exposure. To this end, animals were treated with a chronic binge MA administration paradigm (20. mg/kg/day from postnatal day 91 to 100). Three-age control groups received isovolumetric saline treatment and were tested at the MA age-matched period, and at 12 and 20 months. We observed that both MA and aged animals presented a long, but not short, time impairment in novelty preference and an increased anxiety-like behavior. Neurochemical analysis indicated similar MA- and age-related impairments in dopamine, serotonin and metabolites in the striatum, prefrontal cortex and hippocampus. Thus, the present data illustrate that MA may be used to mimic age-related effects on neurotransmitter systems and advocate MA treatment as a feasible animal model to study neuronal processes associated with aging. {\textcopyright} 2012 Elsevier Inc.},
	keywords = {Accelerated aging, Age Factors, aging, animal behavior, animal experiment, animal model, animal tissue, Animalia, Animals, anxiety, article, behavior change, Behavior, Animal, Brain, Brain Chemistry, controlled study, corpus striatum, dopamine, Exploratory Behavior, hippocampus, Hydroxyindoleacetic Acid, long term exposure, male, Memory Disorders, mental performance, Methamphetamine, Neurochemistry, neurotransmission, nonhuman, perinatal drug exposure, prefrontal cortex, priority journal, rat, Rats, Rats, Wistar, Rattus, recognition, Recognition (Psychology), Recognition memory, serotonin, sodium chloride, Time Factors},
	isbn = {0161813X (ISSN)},
	url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-84861188767\&partnerID=40\&md5=9c50ef658007fb37150c8b2d6d235d29},
	author = {Melo, P. and Magalh{\~a}es, A. and Alves, C.J. and Tavares, M.A. and De Sousa, L. and Summavielle, T. and Moradas-Ferreira, P.}
}
